We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 1,550 results
  1. Synthetic cannabinoids impact on cognitive functions

    Background

    Synthetic cannabinoids SC are now becoming progressively popular among young people worldwide; little is known about their negative...

    Hanan Hany Elrassas, Yasser Abdel Razek Elsayed, ... Zeinab Mohamed El Nagar in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 14 November 2023
  2. Radiological findings in poisoning by synthetic cannabinoids adulterated with brodifacoum

    Objectives

    Severe coagulopathy due to consumption of synthetic cannabinoids adulterated with brodifacoum, a long-acting anticoagulant, is an emerging...

    Nitai Bar, Rebeca Lopez-Alonso, ... Sobhi Abadi in European Radiology
    Article 21 December 2023
  3. Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong

    Purpose

    We report a case of a polydrug user who consumed various synthetic cannabinoids and fentanyl from a transdermal patch via a bucket bong....

    Merja A. Neukamm, Sebastian Halter, ... Marc Bartel in Forensic Toxicology
    Article Open access 10 June 2023
  4. The synthetic cannabinoids menace: a review of health risks and toxicity

    Synthetic cannabinoids (SCs) are chemically classified as psychoactive substances that target the endocannabinoid system in many body organs. SCs can...

    Ayman Alzu’bi, Fatimah Almahasneh, ... Raed M. Al-Zoubi in European Journal of Medical Research
    Article Open access 12 January 2024
  5. Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs

    The aim of the current study is to assess if the patterns of use, socio-demographic characteristics, and use of other drugs differ among people who...

    Hugo López-Pelayo, Santiago Madero, ... João Matias in International Journal of Mental Health and Addiction
    Article 03 October 2022
  6. Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study

    Background

    There is an expanding use of new psychoactive substances containing synthetic cannabinoids in the last years. This study was conducted to...

    Wafaa M. Abdelmoneim, Nagwa M. Ghandour, ... Nora Z. Abdellah in Middle East Current Psychiatry
    Article Open access 30 March 2022
  7. Cannabinoids for Acute Pain Management: Approaches and Rationale

    Purpose of the Review

    Acute pain management remains a challenge and postoperative pain is often undermanaged despite many available treatment options,...

    Mihai O. Botea, Lukas Andereggen, ... Carolina S. Romero in Current Pain and Headache Reports
    Article Open access 12 April 2024
  8. Fatal intoxication with new synthetic cannabinoids 5F-MDMB-PICA and 4F-MDMB-BINACA—parent compounds and metabolite identification in blood, urine and cerebrospinal fluid

    Synthetic cannabinoids (SCs) remain one of the largest groups of new psychoactive substances. Recently, new synthetic cannabinoids 5F-MDMB-PICA and...

    Bogdan Tokarczyk, Agnieszka Jurczyk, ... Piotr Adamowicz in Forensic Science, Medicine and Pathology
    Article 14 June 2022
  9. Cytotoxicity associated with acute and chronic administration of synthetic cannabinoids “Strox” in the brain, liver, heart, and testes of male albino rats: histological and immunohistochemical study

    Background

    Synthetic cannabinoids are one of the largest groups of new psychoactive substances that invaded Egypt’s drug abuse market over the past...

    Wafaa M. Abdelmoneim, Marwa H. Bakr, ... Nora Z. Abdellah in Egyptian Journal of Forensic Sciences
    Article Open access 09 February 2023
  10. Cannabinoids in Symptomatic Treatment for People with Multiple Sclerosis: a Systematic Review of Randomised Studies

    Purpose of Review

    The use of cannabinoid-based medicines in symptomatic treatment for people with multiple sclerosis (MS) is high. This review aimed...

    Graziella Filippini, Silvia Minozzi, ... Kerry Dwan in Current Physical Medicine and Rehabilitation Reports
    Article 18 July 2023
  11. Review: Cannabinoids as Medicinals

    Purpose of review

    There have been many debates, discussions, and published writings about the therapeutic value of cannabis plant and the hundreds of...

    Jag H. Khalsa, Gregory Bunt, ... Marc N. Potenza in Current Addiction Reports
    Article 07 September 2022
  12. Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models

    Purpose

    Synthetic cannabinoids (SCs), highly metabolized substances, are rarely found unmodified in urine samples. Urine screening relies on SC...

    Patrick Dahm, Andreas Thomas, ... Katja Mercer-Chalmers-Bender in Forensic Toxicology
    Article Open access 30 December 2021
  13. Examining the role of cannabinoids on osteoporosis: a review

    Purpose

    Prior research studies have shown that the endocannabinoid system, influenced by CBD and THC, plays a role in bone remodeling. As both the...

    Grace Clouse, Samantha Penman, ... Panayotis K. Thanos in Archives of Osteoporosis
    Article 19 November 2022
  14. Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks

    Introduction

    Pain is a global phenomenon encompassing many subtypes that include neuropathic, musculoskeletal, acute postoperative, cancer, and...

    Samuel P. Ang, Shawn Sidharthan, ... Vwaire Orhurhu in Pain and Therapy
    Article Open access 13 January 2023
  15. Gastrointestinal manifestations of synthetic cannabinoids: a retrospective cohort study

    Background

    Synthetic cannabinoids (SC) are chemical substances which activate cannabinoid receptors similarly to tetrahydrocannabinol, but with a...

    David Hakimian, Ariel A. Benson, ... Mordechai Muszkat in BMC Gastroenterology
    Article Open access 06 July 2021
  16. Semi-quantitative analysis of cannabinoids in hemp (Cannabis sativa L.) using gas chromatography coupled to mass spectrometry

    Background

    Hemp ( Cannabis sativa L.) is a producer of cannabinoids. These organic compounds are of increasing interest due to their potential...

    Luca De Prato, Matthew Timmins, ... Graham O’Hara in Journal of Cannabis Research
    Article Open access 22 September 2022
  17. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

    Background

    Medical cannabinoids differ in their pharmacology and may have different treatment effects. We aimed to conduct a pharmacology-based...

    Ainhoa Bilbao, Rainer Spanagel in BMC Medicine
    Article Open access 19 August 2022
  18. Cannabinoids in the management of behavioral, psychological, and motor symptoms of neurocognitive disorders: a mixed studies systematic review

    Aim

    We undertook this systematic review to determine the efficacy and safety of cannabis-based medicine as a treatment for behavioral, psychological,...

    Anees Bahji, Natasha Breward, ... Darrell D. Mousseau in Journal of Cannabis Research
    Article Open access 14 March 2022
  19. Cannabinoids in the landscape of cancer

    Introduction

    Cannabinoids are a group of terpenophenolic compounds derived from the Cannabis sativa L. plant. There is a growing body of evidence...

    Nagina Mangal, Simon Erridge, ... Mikael Hans Sodergren in Journal of Cancer Research and Clinical Oncology
    Article Open access 14 July 2021
Did you find what you were looking for? Share feedback.